Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

VINBLASTINE SULFATE CRS (5 MG)

VINBLASTINE SULFATE CRS (5 MG)

ND

DISCOVER
VINBLASTINE SULFATE - REFERENCE SPECTRUM (N/A)

VINBLASTINE SULFATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Vinorelbine Ditartrate

Vinorelbine Ditartrate

125317-39-7

DISCOVER
Verapamil HCl

Verapamil HCl

152-11-4

DISCOVER
VINCRISTINE SULFATE CRS (4.96MG)

VINCRISTINE SULFATE CRS (4.96MG)

ND

DISCOVER
VINCRISTINE SULFATE - REFERENCE SPECTRUM (N/A)

VINCRISTINE SULFATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
Des(oxopentyl) Valsartan

Des(oxopentyl) Valsartan

676129-92-3

DISCOVER
Des(oxopentyl) Valsartan Methyl Ester

Des(oxopentyl) Valsartan Methyl Ester

1111177-24-2

DISCOVER
Valnemulin HCl

Valnemulin HCl

133868-46-9

DISCOVER
VINDESINE SULFATE CRS (5 MG)

VINDESINE SULFATE CRS (5 MG)

ND

DISCOVER
VINDESINE SULFATE - REFERENCESPECTRUM (N/A)

VINDESINE SULFATE - REFERENCESPECTRUM (N/A)

NA

DISCOVER
Virginiamycin M1

Virginiamycin M1

21411-53-0

DISCOVER